haemophilia A Archives -

Sanofi eyes 2022 filing for haemophilia drug fitusiran, despite safety issue

https://pharmaphorum.com/news/sanofi-eyes-2022-filing-for-haemophilia-drug-fitusiran-despite-safety-issue/

Scotland’s NHS to fund Roche’s Hemlibra in haemophilia A

https://pharmaphorum.com/news/scotlands-nhs-to-fund-roches-hemlibra-in-haemophilia-a/

Sanofi/Regeneron skin cancer drug among flurry of decisions from EU regulators

https://pharmaphorum.com/news/sanofi-regeneron-skin-cancer-drug-among-flurry-of-approvals-from-eu-regulators/

No US launch until 2020 for Novo’s new haemophilia therapy

https://pharmaphorum.com/news/no-us-launch-until-2020-for-novos-new-haemophilia-therapy/

Roche haemophilia drug gets fast FDA review in expanded use

https://pharmaphorum.com/news/roches-haemophilia-drug-breakthrough-expanded-use-fda/

After losing out on two big deals, Sanofi to buy Bioverativ for $11.6bn

https://pharmaphorum.com/news/losing-two-big-deals-sanofi-buys-bioverativ-11-6bn/

‘Cure for hemophilia within reach’ as BioMarin and Spark gene therapies shine

https://pharmaphorum.com/news/cure-hemophilia-within-reach-biomarin-spark-gene-therapies-shine/

Sangamo and new gene therapy partner Pfizer lifted by FDA fast track

https://pharmaphorum.com/news/sangamo-new-gene-therapy-partner-pfizer-lifted-fda-fast-track/

Search